Catalyst Wire Dossier Catalyst Wire Dossier

nelipepimut-S

nelipepimut-S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for nelipepimut-S, covering 2023-05-16 to 2023-05-16. Get the full timeline:

Most recent: Clinical Trial Update: Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer [Phase 2]

See pricing